Estrogen and autoimmune disease

Clinical Reviews in Allergy and Immunology

Volumn 40, Issue 1, 2011, Pages 60-65

  Walker, Sara E ^a  

^a UNIVERSITY OF MISSOURI   (United States)

Author keywords

Autoimmunity; Estrogen; Multiple sclerosis; Rheumatoid arthritis; Sjogren's syndrome; Systemic lupus erythematosus

Indexed keywords

ESTRADIOL; ESTROGEN; NORETHISTERONE; PREDNISONE;

ARTICLE; FEMALE; HORMONE SUBSTITUTION; HUMAN; OSTEOPOROSIS; POSTMENOPAUSE; PREGNANCY; RHEUMATOID ARTHRITIS; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 79951681305     PISSN: 10800549     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12016-010-8199-x     Document Type: Article

References (70)

1. G Nalbandian S Kovats 2005 Estrogen, immunity & autoimmune disease Curr Med Chem 5 85 91 1:CAS:528:DC%2BD2MXhsFemsrg%3D (Pubitemid 40246737)
2. M Cutolo S Capellino A Sulli, et al. 2006 Estrogens and autoimmune disease Ann NY Acad Sci 1089 538 547 1:CAS:528:DC%2BD2sXhsFeru70%3D 10.1196/annals.1386.043 17261796 (Pubitemid 47092097)
3. TJ Lang 2004 Estrogen as an immunomodulator Clin Immunol 113 224 230 1:CAS:528:DC%2BD2cXovVKltrY%3D 10.1016/j.clim.2004.05.011 15507385 (Pubitemid 39422599)
4. JFG Cohen-Solal L Jeganathan D Kawabata, et al. 2008 Hormonal regulation of B-cell function and systemic lupus erythematosus Lupus 17 528 532 1:CAS:528:DC%2BD1cXoslChsr8%3D 10.1177/0961203308089402 18539705 (Pubitemid 351955427)
5. M Petri 2008 Sex hormones and systemic lupus erythematosus Lupus 17 412 415 1:CAS:528:DC%2BD1cXns1aku7g%3D 10.1177/0961203308090026 18490418 (Pubitemid 351798718)
6. RW Maul PJ Gearhart 2009 Women, autoimmunity, and cancer: a dangerous liaison between estrogen and activation-induced deaminase? J Exp Med 206 11 13 1:CAS:528:DC%2BD1MXhtVOhtb4%3D 10.1084/jem.20080086 19139165
7. G-J Shim LL Kis M Warner, et al. 2004 Autoimmune glomerulonephritis with spontaneous formation of splenic germinal centers in mice lacking the estrogen receptor alpha gene Proc Natl Acad Sci U S A 101 1720 1724 1:CAS:528: DC%2BD2cXhsFaqtLY%3D 10.1073/pnas.0307915100 14745006 (Pubitemid 38236168)
8. KK Bynote JM Hackenbert KS Korach, et al. 2008 Estrogen receptor-alpha deficiency attenuates autoimmune disease in (NZB × NZW)Fl mice Genes Immun 9 137 152 1:CAS:528:DC%2BD1cXivVOktLw%3D 10.1038/sj.gene.6364458 18200028 (Pubitemid 351351656)
9. DJ McCarty S Manzi TA Medsger Jr, et al. 1995 Incidence of systemic lupus erythematosus. Race and gender differences Arthritis Rheum 38 1260 1270 1:STN:280:DyaK28%2Fhs1SmtQ%3D%3D 10.1002/art.1780380914 7575721
10. AD Steinberg BJ Steinberg 1985 Lupus disease activity associated with menstrual cycle J Rheumatol 12 816 817 1:STN:280:DyaL28%2FjslWntQ%3D%3D 4057210
11. CC Mok CS Lau CT Ho, et al. 1999 Do flares of systemic lupus erythematosus decline after menopause? Scand J Rheumatol 28 357 362 1:STN:280:DC%2BD3c7islGjtQ%3D%3D 10.1080/03009749950155346 10665741 (Pubitemid 30033049)
12. CC Mok RW Wong CS Lau, et al. 1999 Ovarian failure and flares of systemic lupus erythematosus Arthritis Rheum 42 1274 1280 1:STN:280:DyaK1M3pt1antg%3D%3D 10.1002/1529-0131(199906)42:6<1274::AID-ANR26>3.0.CO;2-B 10366122 (Pubitemid 29268966)
13. KH Costenbader D Feskanich MJ Stampfer, et al. 2007 Reproductive and menopausal factors and risk of systemic lupus erythematosus in women Arthritis Rheum 56 1251 1262 10.1002/art.22510 17393454 (Pubitemid 46608650)
14. Walker SE (2007) The importance of sex hormones in lupus. In: Wallace DJ, Hahn BH (eds) Dubois' lupus erythematosus, 7th edn. Williams & Wilkins, Baltimore, pp 273-285
15. GS Cooper MA Dooley EL Treadwell, et al. 2002 Hormonal and reproductive risk factors for development of systemic lupus erythematosus. Results of a population-based, case-control study Arthritis Rheum 46 1830 1839 1:CAS:528:DC%2BD38XmtFWgs7k%3D 10.1002/art.10365 12124867 (Pubitemid 34774515)
16. M Ostensen 1999 Sex hormones and pregnancy in rheumatoid arthritis and systemic lupus erythematosus Ann NY Acad Sci 876 131 143 1:CAS:528: DyaK1MXkslGmsbk%3D 10.1111/j.1749-6632.1999.tb07630.x 10415601 (Pubitemid 29352117)
17. A Doria L Iaccarino P Sarzi-Puttini, et al. 2006 Estrogens in pregnancy and systemic lupus erythematosus Ann NY Acad Sci 1069 247 256 1:CAS:528:DC%2BD28XovF2gsLs%3D 10.1196/annals.1351.022 16855151 (Pubitemid 43989867)
18. J Sanchez-Guerrero EW Karlson MH Liang, et al. 1997 Past use of oral contraceptives and the risk of developing systemic lupus erythematosus Arthrits Rheum 40 804 808 1:CAS:528:DyaK2sXjsV2hs7s%3D 10.1002/art.1780400505 (Pubitemid 27199994)
19. S Bl MM Reidenberg S West, et al. 1994 Shingles, allergies, family medical history, oral contraceptives, and other potential risk factors for systemic lupus erythematosus Am J Epidemiol 140 632 642 (Pubitemid 24313020)
20. M Petri MY Kim KC Kalunian J Grossman, et al. 2005 Combined oral contraceptives in women with systemic lupus erythematosus New Engl J Med 353 2550 2558 1:CAS:528:DC%2BD2MXhtlWktrvI 10.1056/NEJMoa051135 16354891 (Pubitemid 41785892)
21. J Sanchez-Guerrero AG Uribe L Jimenez-Santana, et al. 2005 A trial of contraceptive methods in women with systemic lupus erythematosus N Engl J Med 353 2539 2549 1:CAS:528:DC%2BD2MXhtlWlur3E 10.1056/NEJMoa050817 16354890 (Pubitemid 41785891)
22. US Preventive Services Task Force 2005 Hormone therapy for the prevention of chronic conditions in postmenopausal women: recommendations from the U.S. Preventive Services Task Force Ann Int Med 142 885 860
23. J Sanchez-Guerrero MH Liang EW Karlson, et al. 1995 Postmenopausal estrogen therapy and the risk for developing systemic lupus erythematosus Ann Int Med 122 430 433 1:STN:280:DyaK2M7mtVertQ%3D%3D 7856991
24. C Barrett N Neylon ML Snaith 1986 Oestrogen-induced systemic lupus erythematosus Br J Rheumatol 25 300 301 1:STN:280:DyaL283ntVOgtw%3D%3D 10.1093/rheumatology/25.3.300 3730740 (Pubitemid 16037879)
25. FM Calvo-Alen AM Bertoli HM Bastian, et al. 2007 Systemic lupus erythematosus in a multiethnic US cohort (LUMINA L II): relationship between vascular events and the use of hormone replacement therapy in postmenopausal women J Clin Rheumatol 13 261 265 10.1097/RHU.0b013e318156bbf5 17921793 (Pubitemid 47549163)
26. J Sanchez-Guerrero M Gonzalez-Perez M Durand-Darbajal, et al. 2007 Menopause hormonal therapy in women with systemic lupus erythematosus Arthritis Rheum 56 3070 3079 1:CAS:528:DC%2BD2sXht1Ggtb3E 10.1002/art.22855 17763408 (Pubitemid 47502754)
27. JP Buyon MA Petri MY Kim, et al. 2005 The effect of combined estrogen and progesterone hormone replacement therapy on disease activity in systemic lupus erythematosus: a randomized trial Ann Int Med 142 953 962 1:CAS:528: DC%2BD2MXmt1ertb0%3D 15968009
28. D Grady D Herrington V Bittner, et al. 2002 Cardiovascular disease outcomes during 6.8 years of hormone therapy: heart and Estrogen/progestin Replacement Study follow-up (HERS II) JAMA 288 49 57 10.1001/jama.288.1.49 12090862 (Pubitemid 34705518)
29. JE Rossouw GL Anderson RL Prentice, et al. 2002 Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial JAMA 288 321 333 1:CAS:528:DC%2BD38Xltlegs7k%3D 10.1001/jama.288.3.321 12117397 (Pubitemid 34761611)
30. DLT Huong B Wechsler J-C Piette, et al. 1996 Risks of ovulation-induction therapy in systemic lupus erythematosus Br J Rheumatol 35 1184 1186 1:STN:280:DyaK2s7gsVWntQ%3D%3D 10.1093/rheumatology/35.11.1184 8948313
31. P Casoli B Tumiati G La Sala 1997 Fatal exacerbation of systemic lupus erythematosus after induction of ovulation J Rheumatol 24 1639 1640 1:STN:280:DyaK2svgvVKntw%3D%3D 9263164 (Pubitemid 27320711)
32. N Guballa L Sammaritano S Schwartzman, et al. 2000 Ovulation induction and in vitro fertilization in systemic lupus erythematosus and antiphospholipid syndrome Arthritis Rheum 43 550 556 1:STN:280:DC%2BD3c7ptFSqsw%3D%3D 10.1002/1529-0131(200003)43:3<550::AID-ANR10>3.0.CO;2-Y 10728747 (Pubitemid 30394945)
33. LTH Du B Wechsler J-C Piette 2003 Induction d'ovulation et lupus Ann Med Interne 154 45 50 (Pubitemid 36427910)
34. CAA Silva MM Leal C Leone, et al. 2002 Gonadal function in adolescents and young women with juvenile systemic lupus erythematosus Lupus 11 419 425 1:STN:280:DC%2BD38vjvVarsg%3D%3D 10.1191/0961203302lu219oa 12195782
35. SS Shabanova LP Ananieva ZS Alekberova II Guzov 2008 Ovarian function and disease activity in patients with systemic lupus erythematosus Clin Exp Rheumatol 26 436 441 1:STN:280:DC%2BD1cvhtVaqtA%3D%3D 18578965 (Pubitemid 352003212)
36. M Cutolo RG Lahita 2005 Estrogens and arthritis Rheum Dis Clin N Am 31 19 27 10.1016/j.rdc.2004.10.001 (Pubitemid 40082052)
37. KJ Auborn M Qi XJ Yan, et al. 2003 Lifespan is prolonged in autoimmune-prone (NZB/NZW) mice fed a diet supplemented with indole-3-carbinol J Nutr 133 3610 3613 1:CAS:528:DC%2BD3sXovFKgsb8%3D 14608082 (Pubitemid 37409495)
38. LD Apelgren DL Bailey RS Fouts, et al. 1996 The effect of a selective estrogen receptor modulator on the progression of spontaneous autoimmune disease in MRLlpr/lpr mice Cell Immunol 173 55 63 1:CAS:528:DyaK28XmtFejsbY%3D 10.1006/cimm.1996.0251 8871601 (Pubitemid 26344922)
39. ZM Sthoeger H Zinger E Mozes 2002 Beneficial effects of the anti-oestrogen tamoxifen on systemic lupus erythematosus of (NZB×NZW)F1 female mice are associated with specific reduction of IgG3 autoantibodies Ann Rheum Dis 62 341 346 10.1136/ard.62.4.341 (Pubitemid 36363441)
40. E Peeva J Venkatesh B Diamond 2005 Tamoxifen blocks estrogen-induced B cell maturation but not survival J Immunol 75 1415 1423 (Pubitemid 41023040)
41. BD Greenstein YY Dhaher EF de Bridges 1993 Effects of an aromatase inhibitor on thymus and kidney and on oestrogen receptors in female MRL/MP-lpr/lpr mice Lupus 2 2 221 225 1:CAS:528:DyaK2cXht1GhsL8%3D 10.1177/096120339300200403 8268969 (Pubitemid 23295635)
42. E Rose DM Pillsbury 1944 Lupus erythematosus (erythematodes) and ovarian function: observations on a possible relationship, with report of six cases Ann Int Med 21 1022 1034
43. M Laroche S Borg S Lassoued B De Lafontan, et al. 2007 Joint pain with aromatase inhibitors: abnormal frequency of Sjogren's syndrome J Rheumatol 34 2259 2263 1:CAS:528:DC%2BD2sXhsVeksLrM 17937464 (Pubitemid 350076888)
44. JL Cheong R Bucknall 2009 Retinal vein thrombosis associated with a herbal phytoesrogen preparation in a susceptible patient Postgrad Med J 81 266 267 10.1136/pgmj.2004.026369 (Pubitemid 40546626)
45. HP Bhattoa P Bettembuk A Balogh, et al. 2004 The effect of 1-year transdermal estrogen replacement therapy on bone mineral density and biochemical markers of bone turnover in osteopenic, postmenopausal systemic lupus erythematosus patients: a randomized, double-blind, placebo-controlled trial Osteoporos Int 15 396 404 1:CAS:528:DC%2BD2cXjt1Gmtb4%3D 10.1007/s00198-003- 1566-1 14676992 (Pubitemid 38639335)
46. AD Sturgess DT Evans IR Mackay, et al. 1984 Effects of the oestrogen antagonist tamoxifen on disease indices in systemic lupus erythematosus J Clin Lab Immunol 13 11 14 1:STN:280:DyaL2c7ovVeqtg%3D%3D 6371236 (Pubitemid 14177541)
47. CC Mok CH To A Mak, et al. 2005 Raloxifene for postmenopausal women with systemic lupus erythematosus. A pilot randomized controlled study Arthritis Rheum 52 3997 4002 1:CAS:528:DC%2BD28XjvF2hug%3D%3D 10.1002/art.21477 16320346 (Pubitemid 41798239)
48. V Rider X Li G Peterson J Dawson, et al. 2006 Differential expression of estrogen receptors in women with systemic lupus erythematosus J Rheumatol 33 1093 1101 1:CAS:528:DC%2BD28XmtlWmsr4%3D 16755656 (Pubitemid 43825458)
49. YJ Lee KS Shin SW Kang, et al. 2004 Association of the oestrogen receptor alpha gene polymorphisms with disease onset in systemic lupus erythematosus Ann Rheum Dis 63 1244 1249 1:CAS:528:DC%2BD2cXovFOmsrc%3D 10.1136/ard.2003.012583 15361380 (Pubitemid 39273502)
50. M Johansson L Arlestig B Moller, et al. 2005 Oestrogen receptor alpha gene polymorphisms in systemic lupus erythematosus Ann Rheum Dis 64 1611 1617 1:CAS:528:DC%2BD2MXht1eksrjI 10.1136/ard.2004.032425 15817658 (Pubitemid 41532046)
51. NI Abdou V Rider C Greenwell, et al. 2008 Fulvestrant (Faslodex), an estrogen selective receptor downregulator, in therapy of women with systemic lupus erythematosus. Clinical, serologic, bone density, and T cell activation marker studies: a double-blind placebo-controlled trial J Rheumatol 35 797 803 1:CAS:528:DC%2BD1cXntVOmurw%3D 18381791 (Pubitemid 351747119)
52. D Fairweather S Frisancho-Kiss NR Rose 2008 Sex differences in autoimmune disease from a pathological perspective Am J Pathol 173 600 609 1:CAS:528:DC%2BD1cXhtFCit7nO 10.2353/ajpath.2008.071008 18688037
53. E Brahn MN Banquerigo JK Lee, et al. 2008 An angiogenesis inhibitor, 2-methoxyestradiol, involutes rat collagen-induced arthritis and suppresses gene expression of synovial vascular endothelial growth factor and basic fibroblast growth factor J Rheumatol 35 2119 2128 1:CAS:528:DC%2BD1cXhsVKmtrjK 10.3899/jrheum.080302 18792999
54. Y Shoenfeld G Zangman-Goddard L Stojanovich, et al. 2008 The mosaic of autoimmunity: hormonal and environmental factors involved in autoimmune diseases IMAJ 10 8 12 18300563 (Pubitemid 351649455)
55. M Gerosa V De Angelis Riboldi, et al. 2008 Rheumatoid arthritis: a female challenge Women's Health 4 195 201 1:CAS:528:DC%2BD1cXis1ars7c%3D 19072521 (Pubitemid 351513639)
56. T Sokka S Toloza M Cutolo, et al. 2009 Women, men, and rheumatoid arthritis: analyses of disease activity, disease characteristics, and treatments in the QUEST-RA study Arth Res Ther 11 R7
57. RH Straub P Harle F Atzeni, et al. 2005 Sex hormone concentrations in patients with rheumatoid arthritis are not normalized during 12 weeks of anti-tumor necrosis factor therapy J Rheumatol 32 1253 1257 1:CAS:528: DC%2BD2MXnsl2ns7w%3D 15996060 (Pubitemid 40995378)
58. J Rovensky R Kvetnansky Z Radikova, et al. 2005 Hormone concentrations in synovial fluid of patients with rheumatoid arthritis Clin Exp Rheumatol 23 292 296 1:STN:280:DC%2BD2Mzit1WhtQ%3D%3D 15971415 (Pubitemid 40823535)
59. S Capellino P Montagna B Villaggio, et al. 2007 Hydroxylated estrogen metabolites influence the proliferation of cultured human monocytes: possible role in synovial tissue hyperplasia Clin Exp Rheumatol 26 904 909
60. S Capellino B Riepl L Rauch, et al. 2006 Quantitative determination of steroid hormone receptor positive cells in the synovium of patients with rheumatoid arthritis and osteoarthritis: is there a link to inflammation? Ann Rheum Dis 66 53 58 10.1136/ard.2006.055483 16815861 (Pubitemid 46044860)
61. TD Spector MC Hochberg 1989 The protective effect of the oral contraceptive pill on rheumatoid arthritis: an overview of the analytical epidemiological studies using meta-analysis Br J Rheumatol 28 Suppl 11 12 2819342 (Pubitemid 19285680)
62. GM Hall M Daniels EC Huskisson, et al. 1994 A randomized controlled trial of the effect of hormone replacement therapy on disease activity in postmenopausal rheumatoid arthritis Ann Rheum Dis 53 112 116 1:STN:280:DyaK2c7nsFKjtg%3D%3D 10.1136/ard.53.2.112 8129455 (Pubitemid 24087363)
63. AG MacDonald EA Murphy HA Capell, et al. 1994 Effects of hormone replacement therapy in rheumatoid arthritis: a double blind placebo-controlled study Ann Rheum Dis 53 54 57 1:STN:280:DyaK2c7ksFWrug%3D%3D 10.1136/ard.53.1.54 8311557 (Pubitemid 24067410)
64. H Forsblad d'Elia A Larsen L Mattsson, et al. 2003 Influence of hormone replacement therapy on disease progression and bone mineral density in rheumatoid arthritis J Rheum 30 1456 1463 (Pubitemid 36835439)
65. H Forsblad d'Elia L Mattsson C Ohlsson, et al. 2003 Hormone replacement therapy in rheumatoid arthritis is associated with lower serum levels of soluble IL-6 receptor and higher insulin-like growth factor I Arth Res Ther 5 R202 R209 10.1186/ar761
66. H Forsblad d'Elia H Carlsten 2008 The impact of hormone replacement therapy on humoral and cell-mediated immune responses in vivo in post-menopausal women with rheumatoid arthritis Scand J Immunol 68 661 667 10.1111/j.1365-3083. 2008.02186.x 19086108
67. H Maradit-Kremers CS Crowson PJ Nicola, et al. 2005 Increased unrecognized coronary heart disease and sudden deaths in rheumatoid arthritis: a population-based cohort study Arthritis Rheum 52 402 411 10.1002/art.20853 15693010 (Pubitemid 40220344)
68. C Jochems M Lagerquist C Hakansson, et al. 2008 Long-term anti-arthritis and anti-osteopenic effects of raloxifene in established experimental postmenopausal polyarthritis Clin Exp Immunol 152 593 597 1:CAS:528: DC%2BD1cXnvVOiu74%3D 10.1111/j.1365-2249.2008.03660.x 18435803 (Pubitemid 351661511)
69. DC Harnish 2006 Estrogen receptor ligands in the control of pathogenic inflammation Internat Immunol 6 1413 1423 10.1016/j.intimp.2006.04.019 (Pubitemid 44038682)
70. Carlsten H (2007) Interaction with estrogen receptors as treatment of arthritis and osteoporosis. In: Choi Y (ed) Osteoimmunology. Springer, New York, pp 83-92